Skyhawk Therapeutics
Prof. Ben Blencowe is an internationally recognized RNA biologist who has made pioneering contributions to the understanding of the molecular mechanisms controlling alternative splicing and their roles in evolution, development and disease. He holds the Banbury Chair of Medical Research and is Professor in the Donnelly Centre at the University of Toronto; he also serves as Director of the Donnelly Sequencing Centre. Prof. Ben Blencowe has received numerous awards and honours for his research excellence and was recently elected Fellow of the Royal Society (UK). He conducted his Ph.D. research at the European Molecular Biology Laboratory in Heidelberg.
This person is not in the org chart
This person is not in any offices
Skyhawk Therapeutics
1 followers
At Skyhawk Therapeutics we invent small molecules using proprietary kinetic, structural and computational models that correct RNA splicing and mis-spicing. Our small molecule platform accelerates drug development across a broad range of disease types.